Approach to Suspected Thymoma
Demographics and Risk Factors
- Thymomas typically occur in adults 40-70 years of age and are rare in children or adolescents, with higher incidence reported among certain racial and ethnic subgroups, such as Black and Asian individuals, according to the National Comprehensive Cancer Network 1, 2
- Unlike other cancers, alcohol, tobacco smoking, and ionizing radiation do not appear to be risk factors for thymomas, as stated by the National Comprehensive Cancer Network 1
Local Symptoms
- Assess for chest pain, cough, and dyspnea, which are common presenting symptoms, and note that some patients may be completely asymptomatic, with thymoma discovered incidentally on imaging, as recommended by the National Comprehensive Cancer Network 1, 2
Paraneoplastic Syndromes and Autoimmune Disorders
- Thoroughly evaluate for myasthenia gravis symptoms, which occurs in approximately 30-50% of thymoma patients, including drooping eyelids, double vision, difficulty climbing stairs, muscle weakness, hoarseness, dyspnea, and dysphagia, as described by the National Comprehensive Cancer Network 2, 3
- Assess for symptoms of other paraneoplastic syndromes, such as pure red cell aplasia and hypogammaglobulinemia, which occur in less than 10% of thymoma patients, as reported by Annals of Oncology 4, 5
Past Medical History
- Document any history of autoimmune disorders, which may be associated with thymoma, and inquire about previous thymic or mediastinal procedures, as recommended by Annals of Oncology and the National Comprehensive Cancer Network 2, 4, 5
Critical Laboratory Assessments
- Measure anti-acetylcholine receptor antibody levels in all patients with suspected thymoma to rule out subclinical myasthenia gravis, as recommended by the National Comprehensive Cancer Network and Annals of Oncology 3, 4
- Perform a complete blood count with reticulocytes to assess for pure red cell aplasia, and serum protein electrophoresis to evaluate for hypogammaglobulinemia, as reported by Annals of Oncology 4
- Evaluate beta-human chorionic gonadotropin and alpha-fetoprotein to rule out germ cell tumors, as recommended by the National Comprehensive Cancer Network 7